The Minister of State for Health and Secondary Care has today made a written statement to Parliament regarding steps being taken by the NHS to ensure everyone eligible for the Very High Risk Breast Screening Programme has been referred to their local screening centre. Steve Russell, NHS national director for vaccinations and screening, said: “The […]
The NHS is contacting a group of 1,487 women who had radiotherapy above their waist to treat Hodgkin lymphoma when aged between 10 to 35 years during 1962 to 2003 who should have been referred for annual MRI checks (and depending on their age, a mammogram). Why is the NHS contacting this group of women? […]
This service specification relates to children, including adolescents, aged 0 to 15 years up to their 16th birthday who are within the commissioning responsibility of NHS England and who require treatment with external beam radiotherapy (radical, palliative or total body irradiation (TBI)).
Stereotactic ablative body radiotherapy (SABR) is recommended to be available as a treatment option through routine commissioning for adults with locally advanced, inoperable, non- metastatic pancreatic carcinoma (LANPC) within the criteria set out in this document.
Brachytherapy dose escalation with external beam radiotherapy for intermediate- and high-risk localised prostate cancer is recommended as a routine commissioning treatment option within the criteria set out in this policy.
Stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) is not recommended to be available as a treatment option through routine commissioning for the treatment of the surgical cavity following resection of cerebral metastases (all ages).
Stereotactic ablative radiotherapy (SABR) is not recommended to be available as a treatment option for patients with previously irradiated, locally recurrent para-aortic tumours.
Stereotactic ablative radiotherapy (SABR) is recommended to be available as a treatment option through routine commissioning for the treatment of previously irradiated, locally recurrent primary pelvic tumours within the criteria set out in this document.
External beam radiotherapy to the prostate is recommended to be available as a treatment option through routine commissioning for patients presenting with hormone-sensitive, low volume metastatic prostate cancer at the time of diagnosis within the criteria set out in this document.
NHS England will commission stereotactic radiosurgery or radiotherapy for the treatment of meningioma in accordance with the criteria outlined in this document.